Sodium-Glucose Co-transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Breakthrough in Improvement of Clinical Outcomes?
The conventional conception of the therapy of heart failure (HF) with reduced ejection fraction has been recently modified by adding sodium-glucose co-transporter-2 (SGLT2) inhibitors to the combination consisting of beta blockers, mineralocorticoid receptor antagonists, and angiotensin receptor-ne...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2022-05-01
|
| Series: | European Medical Journal |
| Online Access: | https://www.emjreviews.com/european-medical-journal/article/sodium-glucose-co-transporter-2-inhibitors-in-heart-failure-with-preserved-ejection-fraction-a-breakthrough-in-improvement-of-clinical-outcomes-j190221/ |